Livzon Pharmaceutical Group Inc. (SHE:000513)

China flag China · Delayed Price · Currency is CNY
32.67
+0.13 (0.40%)
Apr 28, 2026, 3:04 PM CST
-6.55%
Market Cap 26.63B
Revenue (ttm) 11.71B
Net Income (ttm) 1.96B
Shares Out 887.91M
EPS (ttm) 2.20
PE Ratio 14.82
Forward PE 13.70
Dividend 1.43 (4.39%)
Ex-Dividend Date Jun 13, 2025
Volume 3,789,822
Average Volume 5,422,034
Open 33.10
Previous Close 32.54
Day's Range 32.50 - 33.10
52-Week Range 32.38 - 44.87
Beta 0.38
RSI 36.08
Earnings Date Apr 23, 2026

About SHE:000513

Livzon Pharmaceutical Group Inc. researches, develops, produces, exports, and sells pharmaceutical products, and active pharmaceutical ingredients (API) and intermediates in the People’s Republic of China and internationally. The company offers leuprorelin acetate microspheres, urofollitropin, and menotropins for injection for the assisted reproduction field; Ilaprazole enteric-coated tablets, ilaprazole sodium for injection, and bismuth potassium citrate products for the gastrointestinal field; fluvoxamine maleate for the psychiatric and neuro... [Read more]

Sector Healthcare
Founded 1985
Employees 8,878
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 000513
Full Company Profile

Financial Performance

In 2025, SHE:000513's revenue was 12.02 billion, an increase of 1.76% compared to the previous year's 11.81 billion. Earnings were 2.02 billion, a decrease of -1.84%.

Financial Statements

News

There is no news available yet.